These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 32339244)

  • 1. Intravenous Immunoglobulin-Associated Hemolytic Anemia.
    Jacobs J; Kneib J; Gabbard A
    Lab Med; 2020 Sep; 51(5):e47-e50. PubMed ID: 32339244
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Don't neglect the rare adverse event with intravenous immunoglobulin: Hemolytic anemia.
    Ucar İ; Koyuncu MB; Solmaz AA; Ugurludogan AC; Mercan S; Kucuk M; Unal T; Mazman S; Atilla E
    Transfus Clin Biol; 2023 Feb; 30(1):11-15. PubMed ID: 36028153
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomized trial of anti-D immunoglobulin versus low-dose intravenous immunoglobulin in the treatment of childhood chronic idiopathic thrombocytopenic purpura.
    El Alfy MS; Mokhtar GM; El-Laboudy MA; Khalifa AS
    Acta Haematol; 2006; 115(1-2):46-52. PubMed ID: 16424649
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-D immunoglobulin-induced prolonged intravascular hemolysis and neutropenia.
    Alioglu B; Avci Z; Ozyurek E; Ozbek N
    J Pediatr Hematol Oncol; 2007 Sep; 29(9):636-9. PubMed ID: 17805040
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hemolytic anemia following high dose intravenous immunoglobulin in patients with chronic neurological disorders.
    Markvardsen LH; Christiansen I; Harbo T; Jakobsen J
    Eur J Neurol; 2014; 21(1):147-52. PubMed ID: 24180709
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isoagglutinin-reduced immunoglobulin retains efficacy in mouse models of immune thrombocytopenia and rheumatoid arthritis and is less likely to cause intravenous immunoglobulin-associated hemolysis.
    Cen SY; Branch DR
    Transfusion; 2020 Feb; 60(2):250-255. PubMed ID: 31837028
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of intravenous immunoglobulin (2 g/kg totally) and single doses of anti-D immunoglobulin at 50 μg/kg, 75 μg/kg in newly diagnosed children with idiopathic thrombocytopenic purpura: Ankara hospital experience.
    Alioglu B; Ercan S; Tapci AE; Zengin T; Yazarli E; Dallar Y
    Blood Coagul Fibrinolysis; 2013 Jul; 24(5):505-9. PubMed ID: 23470649
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hemolysis related to intravenous immunoglobulins is dependent on the presence of anti-blood group A and B antibodies and individual susceptibility.
    Mielke O; Fontana S; Goranova-Marinova V; Shebl A; Spycher MO; Wymann S; Durn BL; Lawo JP; Hubsch A; Salama A
    Transfusion; 2017 Nov; 57(11):2629-2638. PubMed ID: 28840942
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The efficacy of different dose intravenous immunoglobulin in treating acute idiopathic thrombocytopenic purpura: a meta-analysis of 13 randomized controlled trials.
    Qin YH; Zhou TB; Su LN; Lei FY; Zhao YJ; Huang WF
    Blood Coagul Fibrinolysis; 2010 Dec; 21(8):713-21. PubMed ID: 20962624
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cerebral sinus thrombosis following IV immunoglobulin therapy of immune thrombocytopenia purpura.
    Al-Riyami AZ; Lee J; Connolly M; Shereck E
    Pediatr Blood Cancer; 2011 Jul; 57(1):157-9. PubMed ID: 21445949
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hemolytic anemia associated with intravenous immunoglobulin.
    Wilson JR; Bhoopalam H; Fisher M
    Muscle Nerve; 1997 Sep; 20(9):1142-5. PubMed ID: 9270670
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A closer look at intravascular hemolysis (IVH) following intravenous anti-D for immune thrombocytopenic purpura (ITP).
    Tarantino MD; Bussel JB; Cines DB; McCrae KR; Gernsheimer T; Liebman HA; Wong WY; Kulkarni R; Grabowski E; McMillan R
    Blood; 2007 Jun; 109(12):5527; author reply 5528. PubMed ID: 17554071
    [No Abstract]   [Full Text] [Related]  

  • 13. Efficacy and safety of a nanofiltered liquid intravenous immunoglobulin product in patients with primary immunodeficiency and idiopathic thrombocytopenic purpura.
    van der Meer JW; van Beem RT; Robak T; Deptala A; Strengers PF
    Vox Sang; 2011 Aug; 101(2):138-46. PubMed ID: 21749402
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravenous immunoglobulin-induced hemolytic anemia after thoracoscopic thymectomy for myasthenia gravis.
    Tsukada H; Sunkara R; Chi DD; Keogh D; Gaissert H
    Ann Thorac Surg; 2014 Jun; 97(6):2175-7. PubMed ID: 24882299
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Appropriateness of intravenous immunoglobulin use in immune thrombocytopenia (ITP): A Canadian centre deep dive audit.
    Liu J; Pavenski K; Sholzberg M
    Transfus Apher Sci; 2019 Aug; 58(4):491-494. PubMed ID: 31105060
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of steroid-resistant idiopathic thrombocytopenic purpura in pregnancy with repeated high-dose intravenous immunoglobulin.
    Kimura S; Kuroda J; Akaogi T; Hayashi H; Ogino Y; Kobayashi Y; Yoshikawa T
    Haematologia (Budap); 2001; 31(3):263-5. PubMed ID: 11855790
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravenous immunoglobulin-related hemolysis in patients treated for Kawasaki disease.
    Luban NL; Wong EC; Henrich Lobo R; Pary P; Duke S
    Transfusion; 2015 Jul; 55 Suppl 2():S90-4. PubMed ID: 26174904
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravenous immunoglobulin-induced hemolytic anemia in a patient with juvenile dermatomyositis.
    Clemenz MR; McGowan Iv JW; Shuler MJ; Lynn AW
    J Drugs Dermatol; 2013 Jan; 12(1):111-3. PubMed ID: 23377338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of childhood acute immune thrombocytopenic purpura with high-dose methylprednisolone, intravenous immunoglobulin, or the combination of both.
    Gereige RS; Barrios NJ
    P R Health Sci J; 2000 Mar; 19(1):15-8. PubMed ID: 10761200
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy, tolerability, safety and pharmacokinetics of a nanofiltered intravenous immunoglobulin: studies in patients with immune thrombocytopenic purpura and primary immunodeficiencies.
    Wolf HH; Davies SV; Borte M; Caulier MT; Williams PE; Bernuth HV; Egner W; Sklenar I; Adams C; Späth P; Morell A; Andresen I
    Vox Sang; 2003 Jan; 84(1):45-53. PubMed ID: 12542733
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.